GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

JAGX · Mar 31, 2026

Jaguar Health, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001193125-26-232560General Corporate

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

43.56% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

815.63% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

38.57% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

94.29% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

50.23% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

19.38% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.76% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History8 statesHistory building

Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/6 normalizedLevel 3 Jun 30, 20250/6 normalizedLevel 3 Sep 30, 20250/7 normalizedLevel 3 Dec 31, 20250/7 normalizedLevel 3 Mar 31, 20260/7 normalizedLevel 3 Jun 30, 20260/7 normalizedLevel 3

Period transition

What moved in the state?

Cash Generation Increased

Previous: -205.77%
Current: 43.56%
Delta: 249.33%

Growth Increased

Previous: -1.52%
Current: 815.63%
Delta: 817.15%

Inventory Pressure Decreased

Previous: 74.70%
Current: 38.57%
Delta: -36.13%

Margin Increased

Previous: 67.21%
Current: 94.29%
Delta: 27.07%

Profitability Increased

Previous: -398.82%
Current: 50.23%
Delta: 449.05%

R And D Intensity Decreased

Previous: 216.89%
Current: 19.38%
Delta: -197.51%

Sbc Intensity Decreased

Previous: 7.22%
Current: 0.76%
Delta: -6.45%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · JAGX Fundamental State →Has State · Jaguar Health, Inc. →Transitioned To · JAGX Fundamental State →Transitioned To · JAGX CASH_GENERATION_INCREASED →Transitioned To · JAGX GROWTH_INCREASED →Transitioned To · JAGX INVENTORY_PRESSURE_DECREASED →Transitioned To · JAGX MARGIN_INCREASED →Transitioned To · JAGX PROFITABILITY_INCREASED →Transitioned To · JAGX R_AND_D_INTENSITY_DECREASED →Transitioned To · JAGX SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.